Invest today or accept a later burden?
Early detection requires access, clinical benefit, organizational effort, financing and potentially avoidable disease burden to be considered together.
Which later consequences stand against today's effort?
Health economics perspective
Health economics makes trade-offs decision-ready.
Health economics is more than an analysis of costs. It asks which benefit should emerge, who carries effort and accountability, how incentives work and whether a good idea remains viable under real care-delivery conditions.
Professional backgroundHealth economics
Operational contextFive practice sites
PerspectiveCare, incentives, implementation
PublicationCommentary on glaucoma screening
Decision framework
Five questions turn good intent into a robust decision.
The sequence is deliberate: only once the intended benefit and affected actors are clear can resources, financing and implementation be assessed meaningfully.
- 01Benefit
What should improve, and for whom?
Define the care objective, affected patient group and expected effect before discussing instruments or prices.
Which benefit would actually matter? - 02Actors and incentives
Who decides, works, pays and benefits?
Make interests, decision rights and burdens visible across the care pathway.
Do accountability and incentives align? - 03Resources
Which scarce capacity is required?
Consider time, staff, rooms, technology and capital, including what can no longer happen elsewhere as a result.
Where does the actual constraint emerge? - 04Financing
Can the structure sustain the intended care?
Assess reimbursement, investment needs, contracting logic and economic risk together.
Who finances setup and ongoing delivery? - 05Implementation and effect
What changes in the real patient pathway?
Translate the decision into workflows, accountability and measurable effects while considering unintended consequences.
How will success become visible in routine care?
Application cases
Three decisions where price alone is not enough.
Health-economic assessment connects the financial view with the effects on care delivery, behavior and feasibility.
Shift the service or merely shift accountability?
Moving care into outpatient settings only becomes viable when financing, investment, staff, capacity and accountability move with the service.
Is the new operating model genuinely workable?Lower purchase price or better overall effect?
Products and technologies need to be assessed through clinical fit, availability, workflow effects, training and patient communication alongside price.
How does the solution change the whole care pathway?
Trade-offs
Four tensions need one decision logic.
Health economics does not resolve conflicting objectives automatically. It makes assumptions, consequences and distributional effects visible enough for accountable decisions.
Not opposites, but not an automatic fit either.
Good care needs financial stability. Financial stability is only meaningful when it supports the care objective.
The lowest price is not automatically the best option.
What matters is the effect that remains after implementation effort, downstream costs, risks and actual use are considered.
Standardization can lower effort and create new dependency.
Scale effects need to be weighed against availability, alternatives, local differences and vulnerability to disruption.
More supply only improves access when navigation works.
Without prioritization, navigation and sufficient capacity, a new offer can reinforce existing constraints.
Entry points
One perspective, four concrete roles.
The same framework leads to different decisions and formats depending on accountability.
Practice and MVZ leadership
Connect care quality, capacity, metrics and financial sustainability in one management system.
View MVZ managementPharma, MedTech and investors
Test market assumptions, provider economics, product adoption and implementation risks realistically.
View healthcare advisoryOrganizers and professional audiences
Structure financing, incentives and care delivery clearly for talks, panels and moderated conversations.
View speaking formatsEditorial teams and media
Explain health-policy and economic relationships without pretending that complex questions have simple answers.
View the media profile
Selected perspectives
Health economics in concrete care-delivery questions.
The contributions examine economic sustainability, outpatient transformation, prevention and product adoption with sources and clearly identified personal perspective.
Economic sustainability and medicine are not opposites
Clinical decisions must be guided by the patient's welfare. At the same time, consistently good care needs financial stability. The problem does not begin with economic thinking, but with misaligned incentives and a lack of transparency.
View contributionOutpatient before inpatient remains rhetoric while financing rewards the opposite
Shifting suitable services into outpatient care is medically and economically plausible. It only works when financing, investment, staff and responsibility move with the service.
View contributionWhy glaucoma screening should be publicly reimbursed
A short summary of a published commentary on the medical, policy and health-economic case for early glaucoma detection.
View contributionOphthalmic biosimilars: the lowest price does not yet create successful care
Biosimilars can strengthen competition and reduce pharmaceutical spending. In intravitreal care, however, clinical fit, availability, contracts, operations and patient communication matter alongside price.
View contribution
Structured tools
Prepare economic questions transparently.
The German-language tools provide an initial structured view of valuation and management. They replace neither a formal company valuation nor legal, tax, financing, investment or medical advice.
Practice valuation
Structure value drivers, risks and transition factors from a buyer or seller perspective.
German interface · free online orientationOpen practice valuationMVZ metrics quick check
Translate a focused set of operating values into a prioritized management view with transparent assumptions.
German interface · online entryReview the metricsMVZ monthly cockpit
Connect performance, capacity, staff and liquidity in a recurring decision cadence.
German interface · cockpit and workbookView monthly managementClear boundary
An analytical perspective, not binding individual advice.
The content and tools support health-economic and managerial assessment. They are not individual medical, legal, tax, financing or investment advice and do not replace a formal company valuation. Medical decisions remain physician responsibilities; patient data does not belong in an initial enquiry.
Frame a health-economic question
Briefly describe the decision, affected actors and intended effect. This makes it possible to identify the assumptions, data and perspectives required for the next step.